noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

California Senate Republican Caucus

🚨BAD BILL ALERT🚨 SENATE REPUBLICANS URGE GOVERNOR: PROTECT TAXPAYERS[...]
U.S. Department of Justice

Two Nigerian Nationals Extradited from Nigeria to the United States to[...]
Public Hospital District No 2 King[...]

See Spot Splash Returns for a 6th Year of Dog-Friendly Fun in Kirkland

Healthcare

Sunshine Biopharma Inc.

08/28/2026 | Press release | Distributed by Public on 08/28/2026 14:06

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 25, 2026, Dr. Andrew Keller, a director of Sunshine Biopharma Inc. (the "Company"), notified the Company that he will not be seeking or accepting reelection to the Board of Directors of the Company upon completion of his current term. Dr. Keller's current term will expire at the Company's next annual shareholder meeting.

Sunshine Biopharma Inc. published this content on August 28, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 28, 2026 at 20:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]